Author:
Bélombé Michel M.,Nenwa Justin,Wankap Kouamo Jean S. T.,Ponou Siméon,Fischer Andreas
Abstract
The crystal structure of the title compound, {[Cu(C4H4O6)(C2H6N4O2)]·4H2O}n, contains the central CuIIcation in a distorted octahedral coordination, symmetrically chelated by the two imine N atoms of a neutral oxamide dioxime (H2oxado) ligand [Cu—N = 1.9829 (16) Å] and unsymmetrically bis-chelated by two halves of the L-(+)-tartrate(2−) (tart) ligands, each half being linked to the CuIIcationviathe deprotonated carboxylate group and protonated hydroxy group [Cu—O = 1.9356 (14) and 2.4674 (13) Å, respectively]. The extended asymmetric unit is defined by twofold axes, one passing through the CuIIcation and the centre of the oxamide dioxime (H2oxado) ligand and the another two (symmetry related) bisecting the central C—C bonds of the tartrate ions. The structure is chiral, consisting of enantiomeric linear-chain polymers oriented along [001], with virtual monomeric {Cu(tart0.5)2(H2oxado)} repeat units and with the chains interleaved face-to-face into `twin pillars'. Nanochannels exist, running parallel to thecaxis and bisectingaandb, which host `double strings' of solvent water molecules. Extensive hydrogen bonding (O—H...O and N—H...O) between the chains and solvent water molecules, together with extended π–σ interactions, consolidate the bulk crystal structure.
Publisher
International Union of Crystallography (IUCr)
Subject
General Biochemistry, Genetics and Molecular Biology,General Medicine
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献